AIDS onset at high CD4+ cell levels is associated with high HIV load

被引:8
作者
Hennessey, KA
Giorgi, JV
Kaplan, AH
Visscher, BR
Gange, S
Margolick, JB
Riddler, S
Phair, J
Detels, R
机构
[1] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angles Ctr Multictr AIDS Cohort Study, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Sch Med, Dept Microbiol, Los Angeles, CA USA
[4] Johns Hopkins Sch Hyg & Publ Hlth, Baltimore, MD USA
[5] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[6] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[7] Northwestern Univ, Sch Med, Chicago, IL USA
关键词
D O I
10.1089/088922200309449
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To identify factors associated with development of AIDS at high CD4(+) cell levels a nested case-control study using data from the Multicenter AIDS Cohort Study (MACS) was conducted. HIV-1-infected men who developed AIDS with greater than or equal to 300/mm(3) CD4(+) cells (AIDS men) were compared to men who had greater than or equal to 300/mm(3) of CD4(+) cells, but remained AIDS free for at least 2 gears. The AIDS men had higher plasma HIV-1 RNA levels (mean 10(5.02) vs. 10(4.42), p < 0.01) and neopterin levels (mean 18.3 vs. 11.5 units/ml, p < 0.05) before the AIDS diagnosis than did the AIDS-free men. A significantly higher proportion of the AIDS men reported genital herpes within the year prior to their initial AIDS diagnosis than did the AIDS-free men (21.9 vs. 4.4%,p < 0.05). The higher viral load at relatively high CD4(+) cell levels in men who subsequently developed AIDS within 6 months supports the hypothesis that elevated levels of HIV precede CD4(+) decline and are the major factor in determining risk of AIDS even at high levels of CD4(+) cell levels.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 1992, J EPIDEMIOLOGY JAPAN
[2]  
Boshoff C, 1997, AIDS Clin Rev, P323
[3]   FACTORS ASSOCIATED WITH PREVALENT HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION IN THE MULTICENTER AIDS COHORT STUDY [J].
CHMIEL, JS ;
DETELS, R ;
KASLOW, RA ;
VANRADEN, M ;
KINGSLEY, LA ;
BROOKMEYER, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (04) :568-577
[4]  
CLOUSE KA, 1989, J IMMUNOL, V143, P470
[5]   PERSISTENT CYTOMEGALOVIRUS-INFECTION OF SEMEN INCREASES RISK OF AIDS [J].
DETELS, R ;
LEACH, CT ;
HENNESSEY, K ;
LIU, ZY ;
VISSCHER, BR ;
CHERRY, JD ;
GIORGI, JV .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :766-768
[6]   Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration [J].
Detels, R ;
Muñoz, A ;
McFarlane, G ;
Kingsley, LA ;
Margolick, JB ;
Giorgi, J ;
Scharager, LD ;
Phair, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1497-1503
[7]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[8]   QUALITY-CONTROL IN THE FLOW CYTOMETRIC MEASUREMENT OF LYMPHOCYTE-T SUBSETS - THE MULTICENTER AIDS COHORT STUDY EXPERIENCE [J].
GIORGI, JV ;
CHENG, HL ;
MARGOLICK, JB ;
BAUER, KD ;
FERBAS, J ;
WAXDAL, M ;
SCHMID, I ;
HULTIN, LE ;
JACKSON, AL ;
PARK, L ;
TAYLOR, JMG .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 55 (02) :173-186
[9]   Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage [J].
Giorgi, JV ;
Hultin, LE ;
McKeating, JA ;
Johnson, TD ;
Owens, B ;
Jacobson, LP ;
Shih, R ;
Lewis, J ;
Wiley, DJ ;
Phair, JP ;
Wolinsky, SM ;
Detels, R .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :859-870
[10]   ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY HERPES-SIMPLEX VIRUS [J].
GOLDEN, MP ;
KIM, SY ;
HAMMER, SM ;
LADD, EA ;
SCHAFFER, PA ;
DELUCA, N ;
ALBRECT, MA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (03) :494-499